Commission Implementing Regulation (EU) 2026/397 of 23 February 2026 authorising the placing on the market of lacto-N-tetraose produced by a derivative strain of Escherichia coli K-12 MG1655 (ATCC 700926) as a novel food and amending Implementing Regulation (EU) 2017/2470
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XII Foodstuffs
Joint committee decision (JCD)
125/2026
In force in the EEA
Yes
Legal Documents
Commission Implementing Regulation (EU) 2026/397 of 23 February 2026 authorising the placing on the market of lacto-N-tetraose produced by a derivative strain of Escherichia coli K-12 MG1655 (ATCC 700926) as a novel food and amending Implementing Regulation (EU) 2017/2470
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2026/397 frá 23. febrúar 2026 um leyfi til að setja á markað laktó-N-tetraósa, sem er framleiddur með afleiddum stofni Escherichia coli K-12 MG1655 (ATCC 700926), sem nýfæði og um breytingu á framkvæmdarreglugerð (ESB) 2017/2470
Durchführungsverordnung (EU) 2026/397 der Kommission vom 23. Februar 2026 zur Genehmigung des Inverkehrbringens von Lacto-N-tetraose aus einem abgeleiteten Stamm von Escherichia coli K-12 MG1655 (ATCC 700926) als neuartiges Lebensmittel und zur Änderung der Durchführungsverordnung (EU) 2017/2470
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.